Comprehensive Study Guide: Pathology of Inflammation, Cellular Ageing, Tissue Repair, and Fluid Dynamics

Fundamentals of Inflammation

  • Definition: Inflammation is the response of vascularized tissues to infections and damaged tissues. It delivers host defense cells and molecules from the circulation to the specific sites where they are needed to eliminate offending agents.

  • Nomenclature: The suffix -itis connotes an inflammatory process (e.g., appendicitis, hepatitis).

  • Etiology / Causes of Inflammation:

    • Infections (bacterial, viral, fungal, parasitic)

    • Tissue necrosis (ischemia, trauma, physical or chemical injury)

    • Foreign bodies (splinters, dirt, sutures)

    • Immune reactions (hypersensitivity and autoimmune responses)

Cardinal Signs of Inflammation

  • Rubor (Redness): Caused by increased blood flow to the inflamed tissue secondary to vasodilation.

  • Calor (Warmth): Caused by increased blood flow to the inflamed tissue secondary to vasodilation.

  • Dolor (Pain): Caused by the increased production and accumulation of pain substances in the inflamed tissue.

  • Tumor (Swelling): Caused by increased vascular permeability leading to fluid accumulation and edema.

  • Functio Laesa (Loss of Function): Caused by tissue damage resulting from the overall inflammatory process.

General Steps of Inflammation

  1. Recognition of the injurious agent.

  2. Recruitment of leukocytes.

  3. Removal of the agent.

  4. Regulation (control) of the response.

  5. Resolution (and repair).

Comparison: Acute vs. Chronic Inflammation

  • Onset:

    • Acute: Fast (onset within minutes or hours).

    • Chronic: Slow (onset over days).

  • Cellular Infiltrate:

    • Acute: Mainly neutrophils.

    • Chronic: Monocytes/macrophages and lymphocytes.

  • Tissue Injury and Fibrosis:

    • Acute: Usually mild and self-limited.

    • Chronic: Often severe and progressive.

  • Local and Systemic Signs:

    • Acute: Prominent.

    • Chronic: Less prominent.

Acute Inflammation: Molecular and Vascular Mechanisms

  • Adhesion Molecules (Three major families controlling leukocyte movement):

    1. Selectins: Control weak attachment and rolling.

    • L-selectin: Expressed on leukocytes.

    • E-selectin and P-selectin: Expressed on endothelial cells.

    1. Immunoglobulin-Family Adhesion Proteins:

    • Includes ICAM-1, ICAM-2, and VCAM expressed on the endothelium.

    • Function: Bind to leukocyte integrins.

    1. Integrins: Control firm adhesion.

    • Examples: LFA-1, MAC-1, VLA-4.

  • Vasoactive Changes:

    • Brief transient vasoconstriction.

    • Followed by arteriolar and venular dilation.

    • Increased blood flow produces redness (rubor) and warmth (calor).

    • Increased vascular permeability allows protein-rich fluid to escape into interstitial tissues, causing edema (tumor).

  • Increased Capillary Permeability:

    • Leads to the leakage of proteinaceous fluid, producing edema.

    • Underlying Mechanisms: Ranges from endothelial cell contraction in postcapillary venules (widening interendothelial gaps) to major direct endothelial damage involving arterioles, capillaries, and venules.

Inflammatory Cell Types and Recruitment

  • Specific Inflammatory Cells:

    • Neutrophils: Prominent during the first 24 hours; characteristic of acute inflammation and bacterial infections.

    • Monocytes/Macrophages: Prominent after 2 to 3 days; longer-lived phagocytes; characteristic of chronic inflammation.

    • Lymphocytes: Prominent in viral infections and chronic inflammation.

    • Eosinophils: Prominent in allergic reactions, asthma, hay fever, and parasitic infections.

    • Mast Cells / Basophils: Responsible for histamine release; involved in allergic and acute inflammatory responses.

  • Leukocyte Emigration and Recruitment Steps:

    CELLULAR RESPONSE OF LEUKOCYTES

    • Emigration: The passage of inflammatory leukocytes between endothelial cells into adjacent interstitial tissue.

    • Sequential Recruitment Steps:

    1. Margination: Peripheral positioning of leukocytes along the endothelial surface.

    2. Pavementing: Alignment of leukocytes lining the endothelial surface.

    3. Rolling (Tumbling): Transient, weak binding and detachment of leukocytes along the endothelium.

    4. Adhesion: Permanent, firm adhesion of leukocytes to the endothelium.

    5. Transmigration: Movement of leukocytes across the endothelium into the tissue space.

  • Chemotaxis:

    • Definition: Process by which leukocytes are attracted to and move toward a site of injury.

    • Chemotactic Factors for Neutrophils:

    1. Bacterial products.

    2. Complement components, especially C5aC5a.

    3. Arachidonic acid metabolites, especially leukotriene B4B_4 (LTB4LTB_4), hydroxyeicosatetraenoic acid (HETE), and kallikrein.

Phagocytosis, Opsonization, and Microbial Killing

  • Phagocytosis:

    • Definition: Ingestion of solid particles such as bacteria, tissue debris, and foreign cells.

    • Primary Phagocytes: Neutrophils and monocytes/macrophages.

    • Sequential Steps: Attachment →\rightarrow Engulfment →\rightarrow Phagosome formation →\rightarrow Phagolysosome formation →\rightarrow Degranulation.

  • Opsonization:

    • Definition: Process that facilitates phagocytosis by coating a target particle with opsonins to enhance recognition and ingestion by phagocytes.

    • Major Opsonins:

    1. IgGIgG: Binds to FcFc receptors on phagocytes.

    2. C3bC3b: Binds to C3bC3b receptors on phagocytes.

  • Intracellular Microbial Killing Mechanisms:

    • Oxygen-Dependent Killing (Most important mechanism):

    • Phagocytosis triggers an oxidative burst where NADPH oxidase produces superoxide (O2−O_2^-).

    • Superoxide converts to hydrogen peroxide (H2O2H_2O_2), which generates reactive oxygen species such as hydroxyl radicals (OH∙OH^\bullet).

    • The Myeloperoxidase–Halide System: Myeloperoxidase (MPO) + H2O2H_2O_2 + Cl−Cl^- destroys microbial proteins and cell walls.

    • Oxygen-Independent Killing (Less effective mechanism):

    • Employs antimicrobial proteins including lysozyme, lactoferrin, defensins, bactericidal/permeability-increasing protein (BPI), and eosinophil major basic protein.

Inflammatory Mediators

  • Exogenous vs. Endogenous Mediators:

    • Exogenous Mediators: Most often of microbial origin (e.g., formylated peptides of Escherichia coli, which are chemotactic for neutrophils).

    • Endogenous Mediators: Derived from host cells or plasma proteins.

  • Vasoactive Amines and Specific Mediators:

    1. Histamine:

    • Parent Amino Acid: Histidine.

    • Sources: Mast cells (richest source), platelets, basophils.

    • Functions: Arteriolar dilation and increased venular permeability.

    1. Serotonin (5-Hydroxytryptamine):

    • Parent Amino Acid: Tryptophan.

    • Sources: Platelets, neuroendocrine cells.

    • Function: Vasoconstriction.

    1. Arachidonic Acid Metabolites / Eicosanoids:

    • Parent Precursor: Arachidonic acid.

    • Cyclooxygenase (COX) Pathway: Produces prostaglandins (PGPG), prostacyclins, and thromboxanes (TXTX).

    • Lipoxygenase Pathway: Produces leukotrienes (LTLT) and lipoxins.

    • Specific Actions:

      • Vasodilation: PGI2PGI_2 (Prostacyclin), PGE1PGE_1, PGE2PGE_2, PGD2PGD_2.

      • Vasoconstriction: TXA2TXA_2, LTC4LTC_4, LTD4LTD_4, LTE4LTE_4.

      • Increased Vascular Permeability: LTC4LTC_4, LTD4LTD_4, LTE4LTE_4.

      • Chemotaxis and Leukocyte Adhesion: LTB4LTB_4, Hydroxyeicosatetraenoic acid (HETE).

    1. Cytokines and Chemokines:

    • Cytokines: Mediate and regulate immune and inflammatory reactions.

    • Chemokines: Serve as chemoattractants for specific types of leukocytes.

    1. Kinin System:

    • Initiated by activation of Factor XII to Factor XIIaXIIa (Hageman factor).

    • Factor XIIaXIIa links four systems: Kinin system, Coagulation system, Fibrinolytic (plasminogen) system, and Complement system.

    • Factor XIIaXIIa converts prekallikrein to kallikrein.

    1. Complement System:

    • Collection of soluble proteins and membrane receptors involved in host defense against microbes and pathologic inflammatory reactions.

    • General Steps: Initiation →\rightarrow Cleavage of C3C3 →\rightarrow Cleavage of C5C5 →\rightarrow Formation of Membrane Attack Complex (MAC).

    • Initiation Pathways:

      • Classical Pathway: Activated by antibodies.

      • Alternative Pathway: Activated by microbial surface products.

      • Mannose-Binding Lectin Pathway: Activated by mannose residues on target cell surfaces.

    1. Nitric Oxide (NONO):

    • Formerly known as endothelium-derived relaxing factor (EDRF).

    • Produced by endothelial cells.

    • Functions: Relaxes smooth muscle to regulate vascular tone; inhibits platelet aggregation, contributing to endothelial thromboresistance.

Outcomes of Acute Inflammation

  1. Resolution: Return to normal tissue structure and function following the removal of the injurious agent.

  2. Tissue Destruction and Persistent Acute Inflammation:

    • Abscess: A pus-filled cavity containing neutrophils, monocytes, and cellular debris; commonly caused by pyogenic bacterial infections, especially staphylococci.

    • Ulcer: Loss of surface epithelium resulting from inflammatory necrosis.

    • Fistula: An abnormal connection or passage between two organs or between an organ and a body surface.

    • Scar: Fibrous tissue replacement following significant tissue destruction, causing structural distortion and functional impairment.

  3. Conversion to Chronic Inflammation:

    • Transition of cellular infiltrate from neutrophils and monocytes to lymphocytes, plasma cells, and macrophages.

    • Marked by increased fibroblast proliferation and new blood vessel formation, resulting in potential fibrosis, scarring, and structural distortion.

Cellular Ageing

  • Definition: Gradual decline in cell function and viability over time.

  • Etiological Factors:

    • Genetic abnormalities.

    • Accumulation of cellular and molecular damage.

    • Effects of external (exogenous) factors.

  • Consequences: Associated with characteristic morphologic (structural) and functional cellular changes.

Chronic Inflammation and Granulomatous Pathology

  • Definition: Inflammation of prolonged duration in which active inflammation, tissue injury, and attempts at repair coexist in varying degrees.

  • Causes:

    • Persistent infections.

    • Hypersensitivity diseases (autoimmune diseases).

    • Prolonged exposure to toxic agents.

  • General Morphologic Features:

    • Infiltration with mononuclear inflammatory cells (lymphocytes, macrophages, plasma cells).

    • Tissue destruction.

    • Attempts at healing via angiogenesis and fibrosis.

  • Subtypes of Chronic Inflammation:

    1. Chronic Nonspecific Inflammation:

    • Dominated by mononuclear cells (macrophages, lymphocytes, plasma cells).

    • Accompanied by fibroblast proliferation and new blood vessel formation, leading to scarring and tissue distortion.

    • Driven by macrophage–lymphocyte interactions: B lymphocytes activated by macrophage-presented antigens turn into plasma cells, which secrete antibodies.

    1. Granulomatous Inflammation:

    • Characterized by granulomas: aggregated collections of activated macrophages called epithelioid cells, surrounded by a rim of lymphocytes.

    • Formed when the body cannot easily eliminate infectious organisms or foreign materials.

    • Mechanism: CD4+CD4^+ T lymphocytes produce IFN−γIFN-\gamma to activate macrophages. Activated macrophages may fuse to form multinucleated giant cells.

    • Necrosis Patterns:

      • Caseous Necrosis: Associated with tuberculosis.

      • Noncaseating Granulomas: Associated with sarcoidosis.

    • Giant Cell Types:

      • Langhans Giant Cells: Nuclei arranged in a horseshoe pattern around the cell margin.

      • Foreign-Body Giant Cells: Nuclei scattered haphazardly throughout the cytoplasm.

    • Etiologies: Infections, foreign bodies, and unknown causes (e.g., sarcoidosis).

Tissue Repair and Regeneration

  • Classification of Tissues by Proliferative Capacity:

    1. Labile Cells: Continuously lost and replaced by proliferation of residual cells or stem cell differentiation (e.g., surface epithelia, hematopoietic stem cells).

    2. Stable Cells: Quiescent cells (G0G_0 phase) with limited proliferative capacity in response to injury (e.g., liver, kidney, pancreas, endothelium, fibroblasts, smooth muscle).

    3. Permanent Cells: Terminally differentiated and non-proliferative (e.g., neurons, cardiac muscle cells, skeletal muscle cells).

  • Cellular Proliferation and Growth Factors:

    • Regulated by growth factors stimulating cell growth, migration, extracellular matrix production, and angiogenesis.

    • Key Factors: Platelet-Derived Growth Factor (PDGF), Epidermal Growth Factor (EGF), Fibroblast Growth Factors (FGFs), Transforming Growth Factors (TGF), Macrophage-derived IL−1IL-1 and TNFTNF.

  • The Repair Process:

    1. Removal of Debris: Initiated early during inflammation; dead cells and debris are liquefied and removed by phagocytes.

    2. Formation of Granulation Tissue: Highly vascularized connective tissue containing new capillaries and fibroblasts. Fills tissue defects left by debris removal. (Granulation tissue is distinct from a granuloma).

  • Factors Impeding Tissue Repair:

    • Retention of debris.

    • Impaired circulation.

    • Persistent infection.

    • Metabolic disorders (especially diabetes mellitus).

    • Nutritional deficiencies:

    • Vitamin C (ascorbic acid) deficiency →\rightarrow impaired collagen formation.

    • Protein deficiency →\rightarrow inadequate collagen production.

Fluid Dynamics: Transudate vs. Exudate and Light's Criteria

  • Definitions:

    • Transudate: Filtered clear fluid characterized by low protein content and low cellularity.

    • Exudate: Inflammatory cloudy fluid characterized by high protein content and high cellularity.

  • Pathophysiology:

    • Transudate: Alteration in systemic pressure balance (Starling forces), driven by increased hydrostatic pressure or decreased plasma oncotic pressure.

    • Exudate: Increased capillary permeability resulting from inflammation and vascular injury.

  • Common Etiologies:

    • Transudate: Congestive Heart Failure (CHF), Cirrhosis, Nephrotic Syndrome.

    • Exudate: Infection (e.g., Pneumonia), Malignancy, Inflammation, Pulmonary Embolism (PE).

  • Fluid Composition and Light's Criteria Thresholds:

    • Protein Content:

    • Transudate: Low (<3 g/dL<3\,g/dL); Fluid/Serum Protein Ratio <0.5<0.5.

    • Exudate: High (>3 g/dL>3\,g/dL); Fluid/Serum Protein Ratio >0.5>0.5.

    • Lactate Dehydrogenase (LDH):

    • Transudate: Low LDH; Fluid/Serum LDH Ratio <0.6<0.6.

    • Exudate: High LDH; Fluid/Serum LDH Ratio >0.6>0.6.

    • Diagnostic Criteria Fulfillment:

    • Transudate: Meets none of Light's criteria.

    • Exudate: Meets at least one of Light's criteria.

  • Comparison Table (Light's Criteria):

    • Protein Content: Transudate is <3 g/dL<3\,g/dL vs. Exudate is >3 g/dL>3\,g/dL.

    • Fluid/Serum Protein Ratio: Transudate is <0.5<0.5 vs. Exudate is >0.5>0.5.

    • Fluid/Serum LDH Ratio: Transudate is <0.6<0.6 vs. Exudate is >0.6>0.6.

  • Clinical Management:

    • Transudate: Manage the underlying systemic condition (e.g., diuretics for volume overload).

    • Exudate: Treat the underlying inflammatory/infectious cause; perform targeted fluid drainage or specific therapy.

  • Key Insights and Mnemonics:

    • Mnemonic: 'T' (Tame: Transudate, clear, low protein) vs. 'E' (Evil: Exudate, cloudy, high protein).

    • Mnemonic Rule: "Exudate = Extra Protein!"

    • Diagnostic Trap: Failing to recognize a parapneumonic effusion as an exudate due to assuming all effusions stem from heart failure.

    • Core Concept: Transudate is caused by a pressure imbalance; Exudate is caused by a vascular barrier failure.